Cetrotide (cetrorelix)
- Region
- 🇪🇺 EU
- Active substance
- cetrorelix
- Company
- Merck Europe B.V.
- Status
- Authorised
- Therapeutic area
- Ovulation; Ovulation Induction
- EU approval
- Mon 12 Apr 1999
- Application
- EMEA/H/C/000233
- ATC
- H01CC02
- Official record
- www.ema.europa.eu
Indication
Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte-pick-up and assisted-reproductive techniques. In clinical trials, Cetrotide was used with human menopausal gonadotropin (HMG), however, limited experience with recombinant follicule-stimulating hormone (FSH) suggested similar efficacy.
Regulatory milestones
No milestones recorded in the last year.
Follow Cetrotide
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.